Provided by Tiger Trade Technology Pte. Ltd.

Karyopharm Therapeutics

5.30
-0.1800-3.28%
Volume:829.74K
Turnover:4.45M
Market Cap:119.48M
PE:-0.30
High:5.57
Open:5.40
Low:5.25
Close:5.48
52wk High:10.99
52wk Low:3.51
Shares:22.54M
Float Shares:21.40M
Volume Ratio:0.16
T/O Rate:3.88%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-17.9300
EPS(LYR):-17.9300
ROE:-891.05%
ROA:-41.56%
PB:-0.41
PE(LYR):-0.30

Loading ...

Feb 12, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 07, 2020

Major Issues Report

Current report, item 5.02
Feb 06, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 05, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Jan 13, 2020

Major Issues Report

Current report, items 2.02 and 9.01
Dec 09, 2019

Major Issues Report

Current report, items 8.01 and 9.01
Nov 18, 2019

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Nov 08, 2019

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Nov 04, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Nov 04, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Sep 16, 2019

Major Issues Report

Current report, items 1.01 and 9.01
Aug 07, 2019

Employee Stock Ownership

Securities to be offered to employees in employee benefit plans
Aug 07, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Aug 06, 2019

Major Issues Report

Current report, items 5.02 and 9.01
Aug 06, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Jul 23, 2019

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Jul 15, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jul 11, 2019

Statement Of Changes In Beneficial Ownership

Initial statement of beneficial ownership of securities
Jul 03, 2019

Major Issues Report

Current report, items 5.02, 8.01, and 9.01
Jun 19, 2019

Major Issues Report

Current report, items 8.01 and 9.01